| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Ohsiek George F. | Chief Accounting Officer | THE CHUBB BUILDING, 17 WOODBOURNE AVENUE, HAMILTON, BERMUDA | /s/ Samantha Froud, Attorney-in-Fact | 17 Feb 2026 | 0002035900 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CB | Common Shares | Options Exercise | $250,040 | +2,112 | +11% | $118.39 | 22,156 | 12 Feb 2026 | Direct | |
| transaction | CB | Common Shares | Sale | $407,923 | -1,240 | -5.6% | $328.97 | 20,916 | 12 Feb 2026 | Direct | F1 |
| transaction | CB | Common Shares | Sale | $1,264,775 | -3,900 | -19% | $324.30 | 17,016 | 13 Feb 2026 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CB | Options to Acquire Common Shares | Options Exercise | $0 | -2,112 | -100% | $0.000000 | 0 | 12 Feb 2026 | Common Shares | 2,112 | $118.39 | Direct | F3 |
| holding | CB | Options to Acquire Common Shares | 14,861 | 12 Feb 2026 | Common Shares | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The Common Shares reported herein as being sold were sold at the same price. |
| F2 | The Common Shares reported herein as being sold were sold at a range of between $323.53 and $324.89 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F3 | Options vested as follows: 1/3 on February 25, 2017, 1/3 on February 25, 2018 and 1/3 on February 25, 2019. |
| F4 | Total includes previously reported options from other tranches with different exercise prices, vesting and expiration dates. |